Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study.
- DOI
- 10.1016/j.ejca.2025.115395
- Published
- 2025 May 15
- Container
- European journal of cancer (Oxford, England : 1990)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2025.115395,
title = {Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study.},
author = {Tahara M and Greil R and Rischin D and Harrington KJ and Burtness B and de Castro G and Psyrri A and Braña I and Neupane P and Bratland Å and Fuereder T and Hughes BGM and Mesía R and Ngamphaiboon N and Rordorf T and Ishak WZW and Lin J and Gumuscu B and Lerman N and Soulières D},
year = {2025},
journal = {European journal of cancer (Oxford, England : 1990)},
doi = {10.1016/j.ejca.2025.115395},
url = {https://doi.org/10.1016/j.ejca.2025.115395}
}RIS
TY - JOUR TI - Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study. AU - Tahara M AU - Greil R AU - Rischin D AU - Harrington KJ AU - Burtness B AU - de Castro G AU - Psyrri A AU - Braña I AU - Neupane P AU - Bratland Å AU - Fuereder T AU - Hughes BGM AU - Mesía R AU - Ngamphaiboon N AU - Rordorf T AU - Ishak WZW AU - Lin J AU - Gumuscu B AU - Lerman N AU - Soulières D PY - 2025 JO - European journal of cancer (Oxford, England : 1990) DO - 10.1016/j.ejca.2025.115395 UR - https://doi.org/10.1016/j.ejca.2025.115395 ER -
APA
M, T., R, G., D, R., KJ, H., B, B., G, D. C., A, P., I, B., P, N., Å, B., T, F., BGM, H., R, M., N, N., T, R., WZW, I., J, L., B, G., N, L., & D, S. (2025). Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2025.115395
Source records
- pubmed · retrieved 2026-09-27T12:13:36.092Z